Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsAntineoplastic Agents, AlkylatingEtoposideThiotepaRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineDisease-Free SurvivalHematopoiesisHodgkin DiseaseCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsSurvival RateTissue DonorsWhole-Body IrradiationSurvival AnalysisDoxorubicinTime FactorsInfectionLymphoma, T-CellDexamethasonePOEMS SyndromePrednisonePlatelet CountHistocompatibilityHistocompatibility TestingCarboplatinImmunosuppressive AgentsAntineoplastic AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicVidarabineBlood Cell CountFollow-Up StudiesRecombinant ProteinsLeukemiaBone Marrow PurgingLymphomaProspective StudiesFatal OutcomeBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesBone MarrowImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationPrognosisLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo ReticularisHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineFlow CytometryBlood DonorsBreast NeoplasmsCell SeparationImmunosuppression